CEACAM5 and neoplasm: Serum GSN (AUC = 0.932) levels are superior to common tumor biomarkers, carcinoembryonic antigen (CEA), or carbohydrate antigen 19–9 (CA199) for colon cancer (Chen et al., 2019b).